Medical devices cover an array products from consumable items to innovative implants and appliances, each serving a particular application or therapeutic area. The medical devices market has seen seismic changes with regional regulations, downwards pricing pressures and advancement in technological standards, equipment and procedures. A&M supports medical device companies in addressing critical objectives with our seasoned industry operators and results-driven approach.
To help deliver sustainable value creation, we support medical device companies and investors in the following areas:
- M&A Strategy, Carve-Outs & Synergy Capture
- Product Innovation & Launch
- Pricing & Reimbursements
- Business Unit / Model Re-design
- Product Margin Improvement
- Sales & Marketing Effectiveness
- Supply Chain Operations
- R&D and Portfolio Review
- Quality Control, Improvement & Compliance
- Regulatory Compliance
- Operating Cost & Working Capital Optimisation
We support a broad range of medical device developers, manufacturers and distributors, our experience covers the following specialist areas:
- Medical Imaging
- In-Vitro Diagnostics
- Orthopaedic Implants & Equipment
- Surgical Equipment & Supplies
- Aesthetic Devices
- Dental
- Ophthalmology
- ENT
- Distributors & Wholesalers
Alvarez & Marsal Expands Infrastructure & Capital Projects Offering Into Canada With The Integration of LQ Consulting And Management
February 9, 2026
Leading global professional services firm Alvarez & Marsal (A&M) announced the integration of LQ Consulting and Management with A&M’s INFRA practice in Canada and appointed Pierre Légaré as Managing Director and Leader of INFRA Canada along with Senior Directors Arshya Qureshi and Gordon Lung.
Virtual Care: Evolving Reimbursement Laws and Strategies for Driving New Revenue Streams
December 3, 2024
Virtual care is transforming healthcare—making it more accessible, efficient, and cost-effective. In A&M Healthcare Industry Group’s latest podcast, we delve into the evolving reimbursement laws and strategies for generating new revenue streams.
Ballad Health is Working to Reduce 100,000 Years of Potential Life Lost
November 20, 2024
Working to reduce 100,000 years of potential life in the communities he serves is just one of the Moonshots that Tony Keck, Executive Vice President for System Innovation and Chief Population Health Officer at Ballad Health is working toward achieving.
Dr. Place is Leading Avera McKennan Hospital & University Health Center to Ensure Its Rural Communities Receive the Same Quality of Care as Urban Areas
October 16, 2024
As President and CEO of Avera McKennan Hospital & University Health Center, Ronald Place, M.D., is committed to ensuring the same level of quality care is delivered to his rural community as in urban areas.
